1 All‐cause mortality |
3 |
967 |
Hazard Ratio (95% CI) |
0.94 [0.73, 1.21] |
1.1 radiotherapy |
2 |
872 |
Hazard Ratio (95% CI) |
0.84 [0.64, 1.11] |
1.2 no radiotherapy |
1 |
95 |
Hazard Ratio (95% CI) |
1.47 [0.84, 2.56] |
2 Local recurrence |
3 |
1404 |
Hazard Ratio (95% CI) |
1.41 [0.94, 2.12] |
2.1 radiotherapy |
2 |
659 |
Hazard Ratio (95% CI) |
1.40 [0.89, 2.19] |
2.2 no radiotherapy |
1 |
745 |
Hazard Ratio (95% CI) |
1.48 [0.58, 3.82] |
3 Axillary recurrence |
1 |
|
Hazard Ratio (95% CI) |
Totals not selected |
4 Locoregional recurrence |
1 |
|
Hazard Ratio (95% CI) |
Totals not selected |
4.1 radiotherapy |
1 |
|
Hazard Ratio (95% CI) |
0.0 [0.0, 0.0] |
4.2 no radiotherapy |
0 |
|
Hazard Ratio (95% CI) |
0.0 [0.0, 0.0] |
5 Distant metastasis |
1 |
|
Hazard Ratio (95% CI) |
Totals not selected |
5.1 radiotherapy |
1 |
|
Hazard Ratio (95% CI) |
0.0 [0.0, 0.0] |
5.2 no radiotherapy |
0 |
|
Hazard Ratio (95% CI) |
0.0 [0.0, 0.0] |
6 Lymphoedema. Increase in arm circumference (≥ 12 months postop) |
1 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
6.1 radiotherapy |
1 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
7 Shoulder lateral rotation (12 months postop) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
7.1 radiotherapy |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
8 Seroma |
1 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
8.1 radiotherapy |
1 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |